Rain Therapeutics Inc.

NASDAQ:RAIN

5.84 (USD) • At close January 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 00000000000000000
Cost of Revenue 00000000000000000
Gross Profit 00000000000000000
Gross Profit Ratio 00000000000000000
Reseach & Development Expenses 003.96514.9816.67719.07814.5114.25713.55514.67215.2845.4895.3284.1727.8931.4731.762
General & Administrative Expenses 30.0434.1135.4145.0664.4793.9013.4613.8953.4053.1542.71.481.280.5911.1190.668
Selling & Marketing Expenses 00000000000000000
SG&A 30.0434.1135.4145.0664.4793.9013.4613.8953.4053.1542.71.481.280.5911.1190.668
Other Expenses 0002.8370000000.001000-1.891-0.005-0.128
Operating Expenses 30.0438.07820.39421.74323.55718.41117.71817.4518.07718.4388.1896.8085.4528.4842.5922.43
Operating Income -3-0.043-8.078-23.231-21.743-23.557-18.411-17.718-17.45-18.077-18.438-8.189-6.808-5.452-8.484-2.592-2.43
Operating Income Ratio 00000000000000000
Total Other Income Expenses Net -0.007-0.0071.0441.1671.2590.8820.370.1070.0560.0940.0120.0060.0080.009-1.962-0.032-0.139
Income Before Tax -3.008-0.05-7.034-22.064-20.484-22.675-18.041-17.611-17.394-17.983-18.426-8.183-6.8-5.443-10.446-2.624-2.569
Income Before Tax Ratio 00000000000000000
Income Tax Expense 00-0.1541.67-1.2590.003-0.37-0.107-0.0560.0020.0010.0060.0080.009-1.820.028-0.097
Net Income -3.008-0.05-7.034-22.064-19.225-22.678-17.671-17.504-17.338-17.985-18.426-8.183-6.8-5.443-10.446-2.624-2.569
Net Income Ratio 00000000000000000
EPS -0.440-0.19-0.61-0.53-0.7-0.67-0.66-0.65-0.68-0.7-0.39-0.26-0.51-0.98-0.25-0.24
EPS Diluted -0.440-0.19-0.61-0.53-0.7-0.67-0.66-0.65-0.68-0.7-0.39-0.26-0.51-0.98-0.25-0.24
EBITDA -3-0.04-7.924-17.54-21.725-23.539-18.393-17.696-17.428-17.983-18.405-8.169-6.785-5.431-10.362-2.579-2.523
EBITDA Ratio 00000000000000000